Results 151 to 160 of about 111,198 (373)
Enhancement of generation of monocyte tissue thromboplastin by bacterial phagocytosis: possible pathway for fibrin formation on infected vegetations in bacterial endocarditis [PDF]
, 1979 C J van Ginkel +4 more
openalex +1 more source
International Journal of Laboratory Hematology, 2016 P. Toulon +6 more
semanticscholar +1 more source
Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders
International Journal of Laboratory Hematology, EarlyView.ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley +1 more source
Calibration of combined thromboplastins with the International Standard for Thromboplastin, rabbit, plain [PDF]
Journal of Thrombosis and Haemostasis, 2011 A. M. H. P. van den Besselaar +2 more
openaire +4 more sources
Separation of Plasma Thromboplastin Antecedent from Kallikrein by the Plasma α2-Macroglobulin, Kallikrein Inhibitor [PDF]
, 1971 Peter C. Harpel
openalex +1 more source
How to report results of prothrombin and activated partial thromboplastin times
Clinical Chemistry and Laboratory Medicine, 2016 A. Tripodi, G. Lippi, M. Plebani
semanticscholar +1 more source
International Journal of Laboratory Hematology, EarlyView.ABSTRACT Introduction Argatroban is routinely monitored using activated partial thromboplastin time (APTT), with a recommended target range of 1.5–3.0 times. Although this range was established based on clinical trial data, including several APTT reagents, the differences in reactivity among APTT reagents remain unclear.
Osamu Kumano +6 more
wiley +1 more source
Concanavalin A Inhibition of Tissue Factor (Thromboplastin) Activity [PDF]
, 1974 Leo R. Zacharski +2 more
openalex +1 more source